The Sensex finished 38 points higher at 3,640 on Thursday. The Nifty closed with a gain of 12 points at 1,146.
The Sensex closed at new high of 7,211 with a gain of 17 points.
'The failures of private businessmen have set back the process of market-oriented reform, though that is the only way forward,' argues T N Ninan.
The Sensex ended up 244 points at 28,504 on strong global cues.
The Sensex staged a smart recovery as it rallied from the day's low of 9897 to a high of 10,093 - up 2% (196 points).
Ranbaxy soared 6.5% to close at Rs 433. Cipla gained 1.6% at Rs 562. Dr.Reddy's, too, was up over 1% at Rs 1,205.
Fortis Healthcare Executive Vice-Chairman Shivinder Mohan Singh is stepping down from his position to join a philosophical and spiritual organisation.
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
The Sensex closed with a gain of 111 points (1.4%) at 8,318.
The Sensex opened with a good positive gap of 18 points at 4,075. It is now up 21 points at 4,078.
The Sensex opened a tad higher at 5,073 - up six points, and is now at 5,081 - up 14 points.
Mirroring buoyant global markets the Sensex opened with a positive gap of 18 points at 5,056. The index is now at 5,075 - up 37 points. The Nifty is at 1,591, up nine points.
The Sensex opened a point higher at 5,104. The index slipped into negative zone and is now at 5,077 - down 26 points. The Nifty is at 1,597 - down seven points.
Mirroring the gains at Wall Steet and strong Asian markets, the Sensex opened with a positive gap of 11 points at 5,263. It moved up a tad to touch a high of 5,269, before slipping into negative zone owing to profit-taking.
The BSE Sensex opened 9 points higher at 5,713. Continued buying has meant that the indices have moved further upwards. The Sensex is now at 5,734, up 30 points.
Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.
The Sensex opened with a positive gap of 11 points at 5,381, it slipped marginally to touch an intra-day low of 5,380.
The Sensex closed with a gain of 16 points at 3,780.\n\n\n\n
FDI in drugs and pharmaceuticals was $487 million during April-August 2012, according to the latest data of the Department of Industrial Policy and Promotion.
Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.
As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.
Sun Pharma profit down 30% over compliance costs, lower sales.
The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.
The 30-share Sensex ended 50 points lower at 28,112 and the 50-share Nifty declined 12 points to close at 8,531.
Today, apologies by CEOs of global corporations have become so common that you get case studies on the subject.
Roadblocks ahead as these medicines could face new clinical tests, more scrutiny
.jpg)
The report comes at a time when the government is trying to clear pending FDI proposals, which include various planned investments in this sector.
Ties between India and the United States have been strained in recent years because of trade policies and patent disputes.
A global policy would reward firms which strive for higher quality.
A glance back at some of the important ups and down Indian Inc faced in 2018.
Shanghvi needs to deploy this excess cash.
Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.
Sachin Bansal, who had co-founded Flipkart with Binny Bansal in 2007, would exit the company
At 15.05 PM, the 30-share Sensex was up 281 points at 28,238 and the 50-share Nifty gained 86 points at 8,577
Various domestic companies such as Ranbaxy, Wockhardt and Agila Specialities recently came under the US FDA scanner for lapse in manufacturing practices.
Top companies added employees at 3% CAGR from 2003-04 to 2013-14, while revenues grew at 18%.
